Q1 FY26 results: standalone loss of Rs 1.51 lakh, new CFO appointed

Revenue declinedNet loss reportedResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.4%Reaction day

₹41.61

prior close

₹43.99

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-0.5% vs market

Non Banking Financial Company (NBFC) peers, median of 210sector-0.4%-0.0% vs sector

On the reaction day the stock moved 0.5 pts less than Nifty Microcap 250 and in line with its Non Banking Financial Company (NBFC) peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-6.0

10m

-2.4

15m

-4.5

30m

-4.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.4+0.1-0.5-0.4-0.0

Next day

-1.6+0.2-1.8-0.7-0.9

-2.3+0.6-2.9-1.3-1.0

-2.2-0.0-2.2-1.8-0.3

-1.7+0.5-2.2-1.6-0.1

-0.6+0.8-1.4-1.1+0.5

-0.1+0.6-0.7-1.2+1.0

15d

+1.1+1.3-0.2-0.9+1.9

-2.9-1.4-1.6-3.1+0.2

-11.9-0.6-11.3-4.4-7.4

—————

UpDownMarket · Nifty Microcap 250Sector · Non Banking Financial Company (NBFC) peers, median of 210Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved Q1 FY26 (June 2026) unaudited results. Standalone revenue from operations fell to Rs 58.36 lakh from Rs 96.07 lakh year on year. Standalone PAT swung to a loss of Rs 1.51 lakh against a profit of Rs 4.18 lakh. Consolidated PAT rose sharply to Rs 454.95 lakh from Rs 279.26 lakh, driven by share of associate profits of Rs 456.46 lakh from Titan Biotech and Peptech Biosciences. Board also appointed Mr Ranjeet Kumar as CFO effective Aug 13, 2026. Auditor Goyal Nagpal and Co issued an unqualified review report.

Likely market impact

Standalone business weak with revenue fall and a small loss, but consolidated profit is strong due to associate income. New CFO appointment is a governance update.